Supreme Court Gene Ruling Splits Hairs Over What's 'Natural'

News & Features Nina Totenberg · ·
A technician loads patient samples into a machine for testing at Myriad Genetics in Salt Lake City in 2002. The Supreme Court ruled Thursday that Myriad cannot patent the BRCA genes, which are tested to check a woman's risk for breast and ovarian cancer.